Literature DB >> 30552748

Protracted glycosuria after discontinuation of sodium-glucose cotransporter 2 inhibitors: Implications for weekly dosing and extended risk of euglycemic diabetes ketoacidosis.

Sharifa Alhassan1,2, Michael Rudoni3, Maria A Alfonso-Jaume4,5, Juan C Jaume1,2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30552748     DOI： 10.1111/1753-0407.12885

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  4 in total

1.  Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis.

Authors:  Siddhartha Dutta; Tarun Kumar; Surjit Singh; Sneha Ambwani; Jaykaran Charan; Shoban B Varthya
Journal:  J Family Med Prim Care       Date:  2022-03-10

2.  Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.

Authors:  Nadine E Palermo; Archana R Sadhu; Marie E McDonnell
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

3.  Nephrology Consultation for Severe SGLT2 Inhibitor-Induced Ketoacidosis in Type 2 Diabetes: Case Report.

Authors:  Felice Nappi; Antonietta La Verde; Giovanni Carfora; Carlo Garofalo; Michele Provenzano; Ferdinando Carlo Sasso; Luca De Nicola
Journal:  Medicina (Kaunas)       Date:  2019-08-10       Impact factor: 2.430

Review 4.  Diabetic ketoacidosis and COVID-19: what have we learned so far?

Authors:  Caio Oliveira de Sá-Ferreira; Camila Helena Macedo da Costa; João Campos Wiltgen Guimarães; Nathasha Souza Sampaio; Leticia de Moraes Lopes Silva; Larissa Paula de Mascarenhas; Nicollas Garcia Rodrigues; Talita Labonia Dos Santos; Solange Campos; Esther Cytrynbaum Young
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-11-15       Impact factor: 4.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.